Roivant Sciences (ROIV) Leases (2021 - 2025)
Roivant Sciences' Leases history spans 5 years, with the latest figure at $83.6 million for Q4 2025.
- For Q4 2025, Leases fell 8.07% year-over-year to $83.6 million; the TTM value through Dec 2025 reached $83.6 million, down 8.07%, while the annual FY2025 figure was $89.0 million, 102.31% up from the prior year.
- Leases reached $83.6 million in Q4 2025 per ROIV's latest filing, down from $85.1 million in the prior quarter.
- In the past five years, Leases ranged from a high of $90.9 million in Q4 2024 to a low of $43.0 million in Q3 2024.
- Average Leases over 5 years is $62.4 million, with a median of $60.2 million recorded in 2022.
- Peak YoY movement for Leases: fell 17.37% in 2024, then soared 102.31% in 2025.
- A 5-year view of Leases shows it stood at $61.7 million in 2021, then dropped by 11.42% to $54.6 million in 2022, then decreased by 14.16% to $46.9 million in 2023, then skyrocketed by 93.81% to $90.9 million in 2024, then fell by 8.07% to $83.6 million in 2025.
- Per Business Quant, the three most recent readings for ROIV's Leases are $83.6 million (Q4 2025), $85.1 million (Q3 2025), and $87.1 million (Q2 2025).